FINCH THERAPEUTICS GROUP INC (FNCH)

US31773D2009 - Common Stock

2.23  -0.07 (-3.04%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
107.00K860.00K18.53M7.72M10.15M
Cost Of Goods
N/AN/AN/A0.00310.00K
Gross Profit
N/AN/AN/A7.72M9.84M
Operating Expenses
34.11M95.98M78.52M47.16M30.99M
Research and Development
7.20M57.89M57.28M33.14M23.54M
Selling, General, and Administrative Expenses
26.91M38.09M21.24M14.01M7.44M
Operating Income
-34.00M-95.12M-59.99M-39.44M-21.14M
Interest Income/Expense
1.57M250.00K20.00K110.00K490.00K
Other Income/Expense
4.05M700.00K-50.00K0.0040.00K
Non Recurring Items
-50.47M-20.47M1.83MN/AN/A
Income Before Taxes
-78.22M-114.65M-58.16M-39.34M-20.75M
Income Tax
-3.46M0.000.000.000.00
Net Income
-74.75M-114.65M-58.16M-39.34M-20.75M
EBITDA
-32.48M-89.61M-57.69M-38.65M-20.66M
 
Per Share Data
EPS Diluted Total Ops
-46.59-72.12-44.39-25.04-13.21
Non GAAP EPS
N/AN/A-13.53N/AN/A
 
Statistics
Gross Profit Margin
N/AN/AN/A100.00%96.95%
Profit Margin
-69863.55%-13331.40%-313.87%-509.59%-204.43%
Operating Profit Margin
-31777.57%-11060.47%-323.75%-510.88%-208.28%

All data in USD

Charts